Mark A. Hlatky

Mark Hlatky is a professor of Health Research and Policy and of medicine (cardiovascular medicine) at Stanford, as well as a CHP/PCOR fellow. His major interests are in outcomes research, evidence-based medicine, and cost-effectiveness analysis. He introduced data collection about economic and quality of life endpoints in several randomized trials, principally trials of therapies for cardiovascular disease.

Hlatky received his MD from the University of Pennsylvania, and, after residency at the University of Arizona, studied as a Robert Wood Johnson Clinical Scholar at the University of California, San Francisco. He trained in cardiology at Duke University Medical Center, and then joined the Duke faculty. He has been at the Stanford University School of Medicine since 1989, where he is currently professor and chair of Health Research and Policy.